| [1] | Turcu A. F., Rege J., Auchus R.J., et al. (2020). 11-oxygenated androgens in health and disease. Nat. Rev. Endocrinol. 16:284−296. DOI:10.1038/s41574-020-0336-x |
| [2] | Walzer D., Turcu A. F., Jha S., et al. (2022). Excess 11-oxygenated androgens in women with severe insulin resistance are mediated by adrenal insulin receptor signaling. J. Clin. Endocrinol. Metab. 107:2626−2635. DOI:10.1210/clinem/dgac365 |
| [3] | McDonnell T., Anthony A. V., Clarke G., et al. (2025). Hepatic metabolism of 11-oxygenated androgens in humans: An integrated in vivo and ex vivo approach. Eur. J. Endocrinol. 193:340−347. DOI:10.1093/ejendo/lvaf166 |
| [4] | Xu H., Zhang H., Yang R., et al. (2026). From testosterone to 11-oxygenated androgens: Integrating endocrine biology, nutrition, and systemic health across the lifespan. Innov. Nutri. 1:100004. DOI:10.59717/j.xinn-nutri.2026.100004 |
| [5] | O'Reilly M. W., Kempegowda P., Jenkinson C., et al. (2017). 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 102:840−848. DOI:10.1210/jc.2016-3285 |
| Zhang X., Xu H., Li J., et al. (2026). 11-Oxygenated androgens: An underrecognized endocrine axis for precision nutrition research. The Innovation Nutrition 1:100018. https://doi.org/10.59717/j.xinn-nutri.2026.100018 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Proposed nutrition–microbiome–insulin framework for 11-oxygenated androgen regulation